Quince Therapeutics Inc. (NASDAQ: QNCX)
$0.76
+0.0100 ( +1.33% ) 51.0K
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
Market Data
Open
$0.76
Previous close
$0.75
Volume
51.0K
Market cap
$32.41M
Day range
$0.75 - $0.79
52 week range
$0.63 - $1.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 02, 2024 |
8-k | 8K-related | 15 | Jan 29, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
8-k/a | 8K-related | 17 | Jan 05, 2024 |
8-k | 8K-related | 13 | Jan 03, 2024 |
8-k | 8K-related | 13 | Dec 22, 2023 |
4 | Insider transactions | 1 | Dec 14, 2023 |
8-k | 8K-related | 13 | Dec 08, 2023 |
4 | Insider transactions | 1 | Dec 07, 2023 |
4 | Insider transactions | 1 | Dec 01, 2023 |